Professor Kevin Harrington - YouTube
Dr. Harrington on the KEYNOTE-048 Trial in Recurrent/Metastatic Head and Neck Cancer
T-VEC injections into melanoma lesions show significant response rate - ecancer
Longtime Fan Uses Ducks Hockey in His Cancer Fight
World's first centre for recurrent head and neck cancer launched - Professor Christopher Nutting Oncology
Amazon | Targeted Therapy for Cancer (Medicine) | Syrigos, Konstantinos N., Harrington, Kevin | Oncology
Potential of immunotherapy in head and neck cancer | VJOncology
Clinical results, patient cases and future developments II: Head & neck cancer – Kevin Harrington on Vimeo
Using Viruses to Treat Cancer | Prof Kevin Harrington | #SCIPEL 2015 | SCI - YouTube
The ICR (@ICR_London) / Twitter
Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer - ecancer
Ducks Fan Harrington Continues His Cancer Fight
ESMO Immuno-Oncology Virtual Congress 2020 | #ESMOImmuno20 Virtual Congress: Prof. Kevin Harrington, Scientific Co-Chair, tells you why this event is so unique. Remember that ESMO Members register... | By ESMO - European
Finder | HCA UK
Professor Kevin Harrington - The Institute of Cancer Research, London
Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile
Scientific Advisory Board – PsiVac
Professor Kevin Harrington | The Royal Marsden
ESMO Immuno-Oncology Congress 2022: Who should take part in this event? - YouTube
Potential of immunotherapy in head and neck cancer | VJOncology
Kevin Harrington | Oncologist in Sutton - Doctify
Royal Marsden researchers named among world's most influential scientists | The Royal Marsden
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
The value of PD-L1 as a biomarker beyond lung cancers - YouTube
Professor Kevin Harrington - The Institute of Cancer Research, London
Scientific Lecture | Kevin Harrington | FRONTAL
